Condition
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02113865Completed
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
NCT00499434Unknown
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
NCT00514111CompletedPrimary
Factors Associated to Success of Hepatitis C Therapy
NCT00512941CompletedPrimary
Laboratory Profile of Hepatitis B and C in Users of a Reference Service
Showing all 4 trials